Tariq Kassum is the founder of Celsius Therapeutics. Celsius Therapeutics has raised $148M in total funding. Latest round: Series B.
Tariq Kassum, M.D., was the former CEO of Celsius Therapeutics, a biotechnology company based in Cambridge, Massachusetts. He led the company from its Series A financing in May 2018 through its acquisition by AbbVie in June 2024 for $250 million. Under his leadership, Celsius Therapeutics advanced its programs to Phase 1 clinical trials and secured additional financing.
Full founder directory · Investor directory · Company funding database · Fundraising library